Therapeutic protocols using ketamine and esketamine for depressive disorders: A systematic review

JM K. Freind, FR Beserra, BS Menezes… - … of Psychoactive Drugs, 2023 - Taylor & Francis
Depression is one of the most prevalent mental health disorders globally, causing severe
emotional suffering, reducing life expectancy and increasing the risk of suicide. Recently, the …

Reconsidering “dissociation” as a predictor of antidepressant efficacy for esketamine

DS Mathai, SM Nayak, DB Yaden… - Psychopharmacology, 2023 - Springer
Rationale The relationship between subjective drug experience and antidepressant
outcomes for ketamine derivatives is poorly understood but of high clinical relevance …

Psychotherapeutic Interventions in Clinical Trials of Psychedelics for the Treatment of Alcohol Use Disorder

A Mohammad Aghaei, J Weleff, B Martins, K Ing… - Current Addiction …, 2024 - Springer
Abstract Purpose of Review Alcohol use disorder (AUD) is the most common substance use
disorder in the USA, with a considerable burden of disease. In recent years, psychedelics …

Mapping consent practices for outpatient psychiatric use of ketamine

DS Mathai, SM Lee, V Mora, KC O'Donnell… - Journal of Affective …, 2022 - Elsevier
Background Given increasing community-based and off-label use of ketamine for psychiatric
indications, we examined current informed consent processes from a convenience sample …

Central nervous system-related safety and tolerability of add-on ketamine to standard of care treatment in treatment-resistant psychotic depression in patients with …

M Gałuszko-Wȩgielnik… - Frontiers in …, 2023 - frontiersin.org
Background Psychotic treatment-resistant depression represents a complex and challenging
form of mood disorder in clinical practice. Despite its severity, psychotic depression is …

Double-Blind Comparison of the Two Hallucinogens Dextromethorphan and Psilocybin: Experience-Dependent and Enduring Psychological Effects in Healthy …

DS Mathai, S Hilbert, ND Sepeda… - Psychedelic …, 2023 - liebertpub.com
Rationale: N-methyl-D-aspartate receptor-mediated dissociatives and serotonergic
hallucinogens are being increasingly used in therapeutic interventions that involve …

[HTML][HTML] Psychedelics for treating psychiatric disorders: Are they safe?

JA Lam, P Mishra, A Aftab - Current Psychiatry, 2022 - mdedge.com
Psychedelics for treating psychiatric disorders: Are they safe? | MDedge Psychiatry Skip to
main content Home Psychiatry ALL Specialities ALL Specialities Home Home / Psychiatry CME …

[HTML][HTML] Current and Emerging Therapies for Bipolar Disorder

MA Burmeister - US Pharm, 2024 - uspharmacist.com
Bipolar disorder (BD) is a complex and lifelong mental health disorder characterized by
episodes of mania, hypomania, and/or depression. Affected individuals are often diagnosed …

A long trip into the universe: Psychedelics and space travel

L Lerer, J Varia - Frontiers in Space Technologies, 2022 - frontiersin.org
Prolonged periods in space have potentially deleterious physiological and psychological
effects. Ensuring the physical health and mental well-being of astronauts will inevitably …

[图书][B] Ketamin: Ein psychoaktives Arzneimittel

M Berger - 2024 - books.google.com
Kaum eine psychoaktive Substanz weist, je nach Dosis und Aufnahmeform, ein so breites
pharmakologisches Spektrum auf wie Ketamin. Die psychotropen Effekte von «Special K» …